# Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments

> **NCT05371483** · — · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Narcolepsy
- Idiopathic Hypersomnia

## Interventions

- **DIAGNOSTIC_TEST:** 24-hour Ambulatory Blood Pressure Monitoring
- **DIAGNOSTIC_TEST:** Oculo-Cognitive Addition Test (OCAT)

## Key facts

- **NCT ID:** NCT05371483
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-05-18
- **Primary completion:** 2026-05
- **Final completion:** 2026-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371483, "Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05371483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*